🔗 Share this article

Chancellor Reeves has announced she is planning "focused action to tackle household expense pressures" in the forthcoming financial statement.

In comments to the BBC, she emphasized that curbing price rises is a shared responsibility of both the administration and the central bank.

The UK's price growth is projected to be the highest among the G7 industrialized countries this year and the following year.

Potential Utility Bill Interventions

Sources suggest the administration could take action to bring down utility costs, for example by cutting the present 5% level of VAT charged on energy.

A further option is to reduce some of the government charges currently added to bills.

Fiscal Constraints and Expert Expectations

The administration will obtain the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these actions.

The view from the majority of experts is that Reeves will have to declare tax increases or expenditure reductions in order to fulfill her voluntary fiscal targets.

Earlier on the same day, calculations suggested there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of projections.

"There's a joint job between the Bank of England and the government to continue tackling some of the causes of price increases," Reeves stated to reporters in the US capital, at the conferences of the IMF and global financial institution.

Tax Commitments and Global Issues

While a great deal of the focus has been on expected tax increases, the chancellor said the most recent information from the OBR had not changed her vow to election pledges not to increase tax levels on earnings tax, VAT or National Insurance.

She blamed an "unpredictable world" with growing international and commercial issues for the Budget tax moves, probably to be focused on those "wealthiest."

International Trade Disputes

Addressing apprehensions about the United Kingdom's economic relations with China she said: "Our national security invariably are paramount."

Recent announcement by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led American leader Donald Trump to propose an extra 100% import tax on imports from China, raising the risk of an all-out trade war between the two global powers.

The American finance chief called the Chinese action "commercial pressure" and "a international production power grab."

Inquired about accepting the US offer to participate in its conflict with China, the Chancellor said she was "deeply worried" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and creates additional obstacles."

"In my view there are sectors where we must address Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium right."

The chancellor also affirmed she was collaborating with other major economies "regarding our own essential resources plan, so that we are less reliant."

Health Service Drug Pricing and Investment

Reeves also recognized that the price the National Health Service pays for medicines could increase as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling projects in the UK, with some attributing the insufficient payments they are getting.

Last month, the government science advisor said the price the NHS spends on medicines would must rise to halt companies and drug research funding departing from the UK.

Reeves informed media: "We have seen as a result of the cost structure, that clinical trials, new drugs have not been offered in the UK in the way that they are in other European countries."

"We want to guarantee that individuals receiving treatment from the National Health Service are can obtain the top life-saving drugs in the globe. And so we are examining all of that, and... looking to obtain increased capital into the UK."